Clinical Trial Update: Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans [Phase 2]

View source ↗

Summary

Phase 2 extension study of cyclosporine inhalation solution in lung and hematopoietic stem cell transplant recipients with bronchiolitis obliterans; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Drugs mentioned

• Cyclosporine Inhalation Solution (cyclosporine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Bronchiolitis Obliterans, Constructive Bronchiolitis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-18